Search results for: 'gene elderly'

The aging phenomenon is rapidly changing the face of demographics and consumer markets globally, with the global elderly to touch 2.1 billion persons by 2050. Aside from Western economies, which have traditionally been associated with aging populations, emerging market economies will see fast-growing aging populations between 2030 and 2050. In the ...

05 Sep 2025  |  Europe  |  Market Research

Growth Opportunities in European Telehealth Market, Forecast to 2030

Profound Demographic Shift in the Elderly Group and Growing Demand for Virtual Care are Driving Transformational Growth by 2030

Infographics

×

The increasing demand for healthcare and a limited workforce have compelled healthcare providers to utilize telehealth channels for care delivery. The European healthcare industry is witnessing an unprecedented shortage of skilled workforce and clinician burnout. Such shortages have significantly burdened the healthcare system, as healthcare demand...

This study highlights advancements such as prime editing, base editing, bridge RNA, SeekRNA, and gene writing platforms, as it examines the emerging field of next-generation gene editing technologies beyond CRISPR/Cas systems. These tools are revolutionary for therapeutic development, precision medicine, and functional genomics because they provide...

As cell and gene therapy (CGT) moves from ultra-rare indications to more common indications, manufacturing capabilities will have to expand to support the commercial requirements of these diseases. Contract research organizations (CROs) can play a critical role in long-term genetic analysis and monitor safety and efficacy up to 15 years after treat...

24 Aug 2021  |  North America  |  Market Research

US and EU Biotech Industry VC Investment Growth Opportunities

Future Growth Potential Driven by Next-generation Cell and Gene Platform Technology Powered by AI

Infographics

×

With this research service, Frost & Sullivan provides critical insights into the biotech, and cell and gene therapy (CGT) venture capital (VC) investment trends highlighting the growth opportunities, key countries in the VC environment, and major trends in cell and gene therapy segment. The study also identifies actionable growth opportunities for ...

23 Oct 2020  |  Global  |  Market Research

Supply Chain Optimization and Decentralized Manufacturing to Expand the Contract Cell and Gene Therapy Manufacturing Market, 2020–2026

Automation Deployed to Contain Cost of Goods Sold and Vector Manufacturing Standardization will Create New Growth Opportunities

Infographics

×

The cell and gene therapy segment is one of the fastest growing segments in the biopharmaceutical space. While the science behind the therapy has grown by leaps and bounds on the back of decades worth of research, manufacturing has unfortunately lagged behind. To fully harness the curative potential of these therapies and ensure greater reach and a...

05 Aug 2024  |  Global  |  Technology Research

CGT Research Outlook and Technology Growth Opportunities

CGT Landscape Assessment

Infographics

×

The CGT landscape has evolved extensively over the past decade. More than 80 CGT products have been commercialized globally, with 34 FDA-approved cell and gene therapies in 2023 alone. The rise in product pipelines and clinical success rates has led to the growing demand for the development of new technology platforms, manufacturing capabilities, a...

The bio‑CDMO industry is entering an era of accelerated growth driven by the global shift toward complex biologics, including monoclonal antibodies, antibody-drug conjugates (ADCs), cell and gene therapies, recombinant proteins, and advanced vaccines. Large molecules are projected to record a 10.3% CAGR between 2025 and 2031, signaling sustained de...

The global care assistance and automation robots market is expected to achieve rapid adoption with a CAGR of 36% through 2021. As doctors and care providers pay more attention to patients, leaving daily tasks for the efficient handling of robotic systems, patients will receive improved quality of care and reduced hospital readmission, the prime rea...